$9.62 Billion is the total value of Carlyle Group Inc.'s 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ATC | Atotech Ltd | $3,921,728,000 | +5.7% | 153,672,703 | 0.0% | 40.75% | +38.8% | |
ZI | Sell | ZoomInfo Technologies Inc | $2,842,650,000 | -23.5% | 44,278,037 | -27.1% | 29.54% | +0.4% |
OCDX | Ortho Clinical Diagnostics H | $2,526,287,000 | +15.7% | 118,106,000 | 0.0% | 26.25% | +52.0% | |
ONEM | 1Life Healthcare Inc | $239,175,000 | -13.2% | 13,612,681 | 0.0% | 2.48% | +13.9% | |
VTRU | Vitru Ltd | $88,075,000 | -11.9% | 6,246,471 | 0.0% | 0.92% | +15.7% | |
SMHI | Seacor Marine Hldgs Inc | $3,903,000 | -26.6% | 1,147,989 | 0.0% | 0.04% | -2.4% | |
SPNT | SiriusPoint Ltd | $1,052,000 | -12.2% | 129,408 | 0.0% | 0.01% | +22.2% | |
ONE | Onesmart Intl Ed Group Ltdsponsored ads | $0 | -100.0% | 7,860,000 | 0.0% | 0.00% | -100.0% | |
TALO | Exit | Talos Energy Inc | $0 | – | -2,325,337 | -100.0% | -0.25% | – |
PPD | Exit | PPD Inc | $0 | – | -55,722,733 | -100.0% | -20.63% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
Enviva Partners LP | 21 | Q2 2020 | 31.5% |
Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
eFFECTOR Therapeutics, Inc. | August 18, 2023 | 4,829,891 | 7.8% |
Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
QuidelOrtho Corp | June 06, 2022 | 12,460,183 | 18.6% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
ARS | 2024-04-18 |
DEF 14A | 2024-04-18 |
DEFA14A | 2024-04-18 |
8-K | 2024-04-03 |
PRE 14A | 2024-04-03 |
4 | 2024-04-02 |
SC 13G | 2024-03-29 |
8-K | 2024-03-27 |
4 | 2024-03-05 |
SC 13D/A | 2024-03-05 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.